Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Various Advanced Cancer × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 104 Colonic Neoplasms 57 Rectal Neoplasms 51 Breast Neoplasms 49 Stomach Neoplasms 30 Pancreatic Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 22 Neoplasm Metastasis 20 Head and Neck Neoplasms 19 Esophageal Neoplasms 19 Esophageal Squamous Cell Carcinoma 14 Adenocarcinoma Of Esophagus 13 Carcinoma, Hepatocellular 12 Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Neoplasms 10 Nasopharyngeal Carcinoma 10 Adenocarcinoma 6 Keratosis, Actinic 5 Anus Neoplasms 5 Urinary Bladder Neoplasms 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Cholangiocarcinoma 4 Inflammatory Breast Neoplasms 3 Hypopharyngeal Neoplasms 3 Hepatoblastoma 3 HIV Infections 3 Anal Canal Carcinoma 3 Uterine Cervical Neoplasms 2

Interventions

Nivolumab 2 Ipilimumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡